Page last updated: 2024-10-23

betaxolol and Exfoliation Syndrome

betaxolol has been researched along with Exfoliation Syndrome in 2 studies

Exfoliation Syndrome: The deposition of flaky, translucent fibrillar material most conspicuous on the anterior lens capsule and pupillary margin but also in both surfaces of the iris, the zonules, trabecular meshwork, ciliary body, corneal endothelium, and orbital blood vessels. It sometimes forms a membrane on the anterior iris surface. Exfoliation refers to the shedding of pigment by the iris. (Newell, Ophthalmology, 7th ed, p380)

Research Excerpts

ExcerptRelevanceReference
" The side effect profile of unoprostone appears to be comparable to other established IOP-lowering agents."6.70A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data. ( Kapik, B; Mertz, B; Nordmann, JP; Schwenninger, C; Shams, N; Yannoulis, NC, 2002)
" The side effect profile of unoprostone appears to be comparable to other established IOP-lowering agents."2.70A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data. ( Kapik, B; Mertz, B; Nordmann, JP; Schwenninger, C; Shams, N; Yannoulis, NC, 2002)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Heijl, A1
Peters, D1
Leske, MC1
Bengtsson, B1
Nordmann, JP1
Mertz, B1
Yannoulis, NC1
Schwenninger, C1
Kapik, B1
Shams, N1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
[NCT00000132]Phase 30 participants Interventional1992-10-31Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

2 trials available for betaxolol and Exfoliation Syndrome

ArticleYear
Effects of argon laser trabeculoplasty in the Early Manifest Glaucoma Trial.
    American journal of ophthalmology, 2011, Volume: 152, Issue:5

    Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Betaxolol; Cohort Studies; Disease Progression; Exfoli

2011
A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data.
    American journal of ophthalmology, 2002, Volume: 133, Issue:1

    Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Betaxolol; Dinoprost; Double-Blind Method; Exf

2002